Integrated Continuous Bioprocess Development for ACE-Inhibitory Peptide Production by Lactobacillus helveticus Strains in Membrane Bioreactor

Production of bioactive peptides (BAPs) by Lactobacillus species is a cost-effective approach compared to the use of purified enzymes. In this study, proteolytic Lactobacillus helveticus strains were used for milk fermentation to produce BAPs capable of inhibiting angiotensin converting enzyme (ACE)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Bioeng Biotechnol
Autors principals: Raveschot, Cyril, Deracinois, Barbara, Bertrand, Emmeline, Flahaut, Christophe, Frémont, Marc, Drider, Djamel, Dhulster, Pascal, Cudennec, Benoit, Coutte, François
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Bioengineering and Biotechnology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7546403/
https://ncbi.nlm.nih.gov/pubmed/33102467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2020.585815
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars